We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

1,035 hedge funds and large institutions have $103B invested in Allergan plc in 2015 Q2 according to their latest regulatory filings, with 126 funds opening new positions, 393 increasing their positions, 410 reducing their positions, and 169 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less capital invested

Capital invested by funds: $105B → $103B (-$1.89B)

4% less repeat investments, than reductions

Existing positions increased: 393 | Existing positions reduced: 410

4% less call options, than puts

Call options by funds: $1.15B | Put options by funds: $1.2B

3% less funds holding in top 10

Funds holding in top 10: 182176 (-6)

5% less funds holding

Funds holding: 1,0891,035 (-54)

25% less first-time investments, than exits

New positions opened: 126 | Existing positions closed: 169

Holders
1,035
Holders Change
-54
Holders Change %
-4.96%
% of All Funds
27.88%
Holding in Top 10
176
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-3.3%
% of All Funds
4.74%
New
126
Increased
393
Reduced
410
Closed
169
Calls
$1.15B
Puts
$1.2B
Net Calls
-$50.7M
Net Calls Change
-$421M
Name Holding Trade Value Shares
Change
Change in
Stake
ACP
701
Ashfield Capital Partners
California
$1.35M
SHA
702
Smith Hayes Advisers
Nebraska
$1.34M +$1.32M +4,430 New
Rafferty Asset Management
703
Rafferty Asset Management
New York
$1.34M -$517K -1,734 -28%
FT
704
Fiduciary Trust
Massachusetts
$1.33M +$1.31M +4,389 New
TCM
705
Twin Capital Management
Pennsylvania
$1.32M +$29.5K +99 +2%
YIA
706
YHB Investment Advisors
Connecticut
$1.31M +$53.4K +179 +4%
CS
707
Comerica Securities
Michigan
$1.29M +$235K +787 +23%
PM
708
Penbrook Management
New York
$1.28M +$315K +1,057 +33%
Two Sigma Investments
709
Two Sigma Investments
New York
$1.27M +$1.25M +4,200 New
VKH
710
Virtu KCG Holdings
New York
$1.24M -$9.74M -32,643 -89%
BIM
711
Baldwin Investment Management
Pennsylvania
$1.22M +$61.1K +205 +5%
AAP
712
Ardsley Advisory Partners
Connecticut
$1.21M
USGIU
713
U.S. Global Investors (USGI)
Texas
$1.21M
F
714
FolioMetrix
Nebraska
$1.2M +$59.1K +198 +4%
SCM
715
Stevens Capital Management
Pennsylvania
$1.18M -$15.7M -52,633 -93%
TCM
716
Tributary Capital Management
Nebraska
$1.16M +$895K +3,000 +370%
CONA
717
Capital One National Association
New York
$1.14M -$184K -617 -14%
PGA
718
Portland Global Advisors
Maine
$1.14M +$29.8K +100 +3%
CAM
719
CG Asset Management
New York
$1.12M +$441K +1,480 +67%
DC
720
Davenport & Co
Virginia
$1.12M -$447K -1,500 -29%
WC
721
Whitnell & Co
Illinois
$1.12M
PAG
722
Private Advisor Group
New Jersey
$1.11M +$254K +851 +30%
BRWA
723
B. Riley Wealth Advisors
Florida
$1.11M +$81.1K +272 +8%
WP
724
WealthPLAN Partners
Nebraska
$1.09M -$2.09K -7 -0.2%
Fisher Asset Management
725
Fisher Asset Management
Washington
$1.09M +$103K +347 +11%

AGN Hedge Fund Activity: Q2 2015 in Review

1,035 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q2 2015, worth a combined $103B — down 1.8% from $105B a quarter earlier.

Sellers outnumbered buyers: 169 funds closed out of AGN and 126 opened new positions — a net loss of 43 holders — while 410 trimmed existing stakes and 393 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $564M. The largest seller was Geode Capital Management, exiting entirely with an estimated $901M sold.

  • 1,035 institutional investors held Allergan plc (AGN) as of Q2 2015, down from 1,089 in Q1 2015.
  • Funds reported $103B of Allergan plc stock for Q2 2015, down 1.8% quarter-over-quarter.
  • 126 funds opened new Allergan plc positions in Q2 2015 and 169 closed out, a net change of -43 holders.
  • The largest Allergan plc buyer in Q2 2015 was T. Rowe Price Associates, an estimated $564M added.
  • The largest Allergan plc seller in Q2 2015 was Geode Capital Management, an estimated $901M sold.

Based on aggregated 13F filings for Q2 2015.